Mesenchymal stromal cells (MSCs) from bone marrow of low-risk MDS patients were FAK deficient. This finding was associated with morphological and functional changes of MSCs and to an altered hematopoiesis, in particular with an impaired erythroid differentiation. This evidence concerns the gene PTK2 and myelodysplastic syndrome.